Effect of amorphous content on dissolution characteristics of rifampicin
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Poster
- By: PANCHAGNULA, Ramesh (University of Ulster, Coleraine, United Kingdom)
- Co-author(s): Bharadwaj, Vivekananda (NIPER, MOHALI, India)
Rifampicin, one of the main first line anti-TB drugs shows variable bioavailability in different marketed preparations and reasons cited include physiological, degradation, manufacturing/ processing, solid state and bioavailability assessment procedure. Although the amorphous form of a drug is expected to exhibit higher solubility, the amorphous.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.